Article
Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis.
PloS one - 1 Jan 2012
Wu Muzhou, Nissen Jillian C, Chen Emily I, Tsirka Stella E
Abstract excerpt
Multiple sclerosis (MS) is a demyelinating autoimmune disease mediated by infiltration of T cells into the central nervous system after compromise of the blood-brain barrier. We have previously shown that administration of tuftsin, a macrophage/microglial activator, dramatically improves the clinical course of experimental autoimmune encephalomyelitis (EAE), a well-established animal model for MS. Tuftsin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
